The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, continues its international growth strategy with the opening of a new subsidiary in the Czech Republic, where it already operates through distribution agreements. The new subsidiary will have a sales team specialized in the pharmaceutical market and with the collaboration of a local partner (LERAM Pharma).
With the incorporation of its innovative products into the new subsidiary, the company aims to further promote the growth of the osteoarticular health and dermatology sectors in the Czech Republic, providing a differentiated value that improves the quality of life of patients and strengthens their leadership in these therapeutic areas. In the future, the incorporation of the other products of the company will be considered, after completing the relevant registration processes in the Czech market.
The expansion of Reig Jofre focuses on internationalization as a growth engine, supported both by the creation of subsidiaries in strategic markets in Europe and by the formalization of distribution agreements in key countries. The company extends its business model in the Czech Republic, with the first sales planned for this second half of 2024, strengthening its presence in strategic markets for the company and consolidating its global growth plan.
Related news:
Comments